NCT04799483View on ClinicalTrials.gov

Safety and Survival of Genetically Modified White Blood Cells in HIV-infected Twins The Gemini Study

Active, not recruitingOBSERVATIONAL

Enrollment

32

Participants

Timeline

Start Date

January 5, 2001

Primary Completion Date

January 1, 2030

Study Completion Date

January 30, 2030

Conditions

HIV

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH